Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-vs-Host Disease

C. Ferrándiz-Pulido
Actas Dermosifiliogr 2018;109:200-1

Full text - PDF

https://ift.tt/2HCLnhK